The European Society for Hemapheresis - short ESFH - was founded in 1984 with the aim of gathering European physicians, scientists, and allied health personnel working in the field of Hemapheresis with a vision to improve donor and patient care. The mission of ESFH is to advance knowledge in apheresis techniques through education, to consolidate and spread proven methods, and to open new paths in the collection of blood cells and treatment of diseases by apheresis.

Learn More

From the literature:

 22nd ESFH CONGRESS
which will be held as a hybrid joint meeting of the
Turkish Hematology Society, WAA and ESFH:
September 14th – 17th, 2022, Istanbul, Turkey

Congress Istanbul 2022

Download Flyer   

Message from the ESFH president

Preliminary Program   Website : http://waa2022.org/

Registration 

 Previous ESFH Congress; Content for download
21
st  Congress    2021,  May 26th - 27th  Digital  PROGRAM
    Presentations  and Session Videos

H. Vrielink Convalescent Plasma: from whom and when (pdf) 
Video
 Hans Vrielink  MD PhD: Convalescent plasma: from whom and when
M.Lozano  Apheresis techniques in the treatment of severe COVID-19 patients (pdf)
Video:Miquel Lozano: Apheresis techniques in the treatment of severe COVID-19 patients
L.Pierelli  Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic(pdf)
Video  Luca Pierell:
Clinical impact of allogeneic stem cells cryopreservation during COVID-19 pandemic
M.-J Mustieles:Vascular Aaccess: Always Central Line?  (pdf)
Video  M.J. Mustieles
:Vascular Aaccess: Always Central Line?
Video Marie Scully:
New treatment strategies in management of TTP

Webinars produced  by  Terumo BCT with the collaboration of ESFH
Previous 
WAA  WEBINAR September 15, 2021, 12:00 pm -2:00pm (EST)
Role of Apheresis in Cellular Therapies and Thrombosis Following COVID- 19
 https://us02web.zoom.us/webinar/register/WN_61FziquaSTGXv7uj0R1DiQ


 On-Demand WebinarOne Year In: Lessons Learned About Transfusion of Convalescent Plasma (CP) for COVID-19
Register Now                     Presented by
Dr. Miquel Lozano, Chief, Hemotherapy Section, Hospital Clinic de Barcelona, Spain
Dr. Claudia Cohn, Chief Medical Officer, AABB
Dr. Leandro Burgos Pratx, Executive Chief of the Service of Transfusion Medicine, Hospital Italiano of Buenos Aires, Brazil
Dr. Silvano Wendel, Medical Director, Hospital Sirio Libanes São Paulo,
Brazil
Deirdre Fehily, PhD, Policy Officer – Substances of Human Origin Team, European Commission             

Previous ESFH Congress 

ESFH 21th Congress
2021,May 26th - 27th Digital (rescheduled)

ESFH 20th Congress  2018
13th/14th June 2018 Hospital La Fe, Valencia, Spain

 

 

Recently an interesting investigation was published in Vox Sanguinis concerning in vitro evaluation of buffy coat derived granulocytes for the...
In this paper, the group from Pamplona shows data of stem cell mobilization with filgrastim (G-CSF) in 36 healthy family donors, of which 18...
In this paper the authors reviewed more than 50.000 extracorporeal procedures in 7.142 patients regarding incidence and severity of apheresis...